Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

QUAKER CHEMICAL CORP Director's Dealing 2017

Nov 2, 2017

31579_dirs_2017-11-02_f26f1d6c-1a29-43b7-a1b6-d248db728ff7.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: QUAKER CHEMICAL CORP (KWR)
CIK: 0000081362
Period of Report: 2017-11-01

Reporting Person: STEEPLES ADRIAN (VP & Managing Director - A/P)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2017-11-01 Common Stock M 2209 $73.47 Acquired 6193 Direct
2017-11-01 Common Stock S 87 $157.135 Disposed 6106 Direct
2017-11-01 Common Stock S 2122 $154.7759 Disposed 3984 Direct
2017-11-01 Common Stock M 1489 $87.30 Acquired 5473 Direct
2017-11-01 Common Stock S 275 $156.9164 Disposed 5198 Direct
2017-11-01 Common Stock S 1214 $155.5382 Disposed 3984 Direct
2017-11-01 Common Stock M 1213 $72.12 Acquired 5197 Direct
2017-11-01 Common Stock S 1213 $157.135 Disposed 3984 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2017-11-01 Employee Stock Option (right to buy) $73.47 M 2209 Disposed 2021-02-27 Common Stock (2209) Direct
2017-11-01 Employee Stock Option (right to buy) $87.30 M 1489 Disposed 2022-02-25 Common Stock (1489) Direct
2017-11-01 Employee Stock Option (right to buy) $72.12 M 1213 Disposed 2023-02-23 Common Stock (1213) Direct

Footnotes

F1: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $154.43 to $155.38, inclusive. The reporting person undertakes to provide to Quaker Chemical Corporation ("Quaker"), any security holder of Quaker, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (1) to this Form 4.

F2: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $156.785 to $157.10, inclusive. The reporting person undertakes to provide to Quaker Chemical Corporation ("Quaker"), any security holder of Quaker, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4.

F3: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $155.38 to $155.77, inclusive. The reporting person undertakes to provide to Quaker Chemical Corporation ("Quaker"), any security holder of Quaker, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (3) to this Form 4.

F4: The options for this grant vested in three annual installments: 737 shares on February 27, 2015; 736 shares on February 27, 2016; and 736 shares on February 27, 2017.

F5: The options for this grant vest in three annual installments: 745 shares on February 25, 2016; 744 shares on February 25, 2017; and 744 shares on February 25, 2018.

F6: The options for this grant vest in three annual installments: 1,213 shares on February 23, 2017; 1,213 shares on February 23, 2018; and 1,213 shares on February 23, 2019.